[Present status of infectious keratitis].
Shimomura
Yoshikazu
Y
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects / Q000235:genetics; D001424:Bacterial Infections; D027081:DNA Gyrase / Q000235:genetics; D027101:DNA Topoisomerase IV / Q000235:genetics; D004269:DNA, Bacterial / Q000096:biosynthesis; D024881:Drug Resistance, Bacterial / Q000235:genetics; D006801:Humans; D007634:Keratitis / Q000188:drug therapy* / Q000382:microbiology* / Q000469:parasitology; D009154:Mutation; D009883:Ophthalmic Solutions
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D009883:Ophthalmic Solutions; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase